Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Epilepsia|August 23, 2022
Rescue therapies for seizure clusters: Pharmacology and target of treatmentsBarry Gidal, Kamil Detyniecki
Therapeutic Drug Monitoring|November 2, 2021
Interindividual Variability in the Bioavailability of Gabapentin Enacarbil Extended Release in Healthy Adults: An Analysis of Data From 6 Phase I StudiesRitu Lal, Aaron Ellenbogen, Barry Gidal
Epilepsy & Behavior : E&B|September 8, 2020
Seizure clusters, rescue treatments, seizure action plans: Unmet needs and emerging formulationsBarry Gidal, Pavel Klein, Lawrence J Hirsch
Cleveland Clinic Journal of Medicine|September 24, 2004
Bone disease associated with antiepileptic drugsAlison M Pack, Barry Gidal, Blanca Vazquez
Acta Neurologica Scandinavica|May 21, 2020
Changes in perampanel levels during de-induction: Simulations following carbamazepine discontinuationEdgar Schuck, Jim Ferry, Barry Gidal, et al.
Therapeutic Drug Monitoring|March 19, 2013
Assessing impact of real-world dosing irregularities with lamotrigine extended-release and immediate-release formulations by pharmacokinetic simulationChao Chen, James Wright, Barry Gidal, et al.
Epilepsy Research|February 24, 2020
Effects of enzyme-inducing antiseizure medication on vitamin D dosing in adult veterans with epilepsyNathan Menninga, Yannis Koukounas, Amanda Margolis, et al.
CNS Drugs|March 5, 2019
Correction to: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy SubjectsLesley Taylor, Barry Gidal, Graham Blakey, et al.
CNS Drugs|October 31, 2018
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy SubjectsLesley Taylor, Barry Gidal, Graham Blakey, et al.
Paediatric Drugs|October 30, 2023
Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet NeedsJames W Wheless, Barry Gidal, Adrian L Rabinowicz, et al.
Pageof 4